CASE REPORT
Accepted on 16 Dec 2025
Case Report: Autologous Stem Cell Boost Enables Hematopoietic Recovery After Severe Cytopenia Induced by BCMA-Targeted Bispecific Antibody Therapy in Multiple Myeloma
- 242 views
- Frontiers in Oncology
- Hematologic Malignancies
- Research Topics
- Chimeric Antigen Receptor T Cell Therapies and Bispecific Antibodies in Hematologic Malignancies
Chimeric Antigen Receptor T Cell Therapies and Bispecific Antibodies in Hematologic Malignancies
870
Total downloads
12k
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
METHODS
Published on 19 Nov 2025
Proposed observational study protocol for early differentiation of cytokine release syndrome and sepsis in CAR-T recipients with haematological malignancies using the IL-6/PCT ratio: the DRACARYS study
doi 10.3389/fonc.2025.1683350
- 1,109 views
CASE REPORT
Published on 29 Oct 2025
Case Report: CD19 and CD22 CAR-T therapy induced durable complete remission in a patient with refractory plasmablastic lymphoma
doi 10.3389/fimmu.2025.1697566
- 1,421 views
ORIGINAL RESEARCH
Published on 27 Oct 2025
Post-progression outcomes following BCMA-directed CAR T-cell therapy in myeloma: impact of extramedullary and paramedullary disease
doi 10.3389/fonc.2025.1663814
- 1,739 views
SYSTEMATIC REVIEW
Published on 29 Sep 2025
CAR T-cells vs. bispecific antibodies as third- or later-line treatment for relapsed/refractory follicular lymphoma: a literature review and meta-analysis
doi 10.3389/fimmu.2025.1611984
- 4,576 views
CASE REPORT
Published on 18 Sep 2025
Case Report: Safety and efficacy assessment of teclistamab in relapsed/refractory amyloidosis: a case study
doi 10.3389/fonc.2025.1664171
- 1,569 views
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
You will be redirected to our submission process.